Global registry to monitor Long-Term safety of short bowel syndrome treatment
NCT ID NCT01990040
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 27 times
Summary
This study is a worldwide registry that follows people with short bowel syndrome over many years to see how safe the drug teduglutide is and how their health changes over time. It includes both people who take teduglutide and those who do not. The goal is to better understand long-term risks, such as cancer, and other health outcomes in routine medical care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shire
Lexington, Massachusetts, 02421, United States
Conditions
Explore the condition pages connected to this study.